229 related articles for article (PubMed ID: 19715280)
1. Heterogeneous nuclear ribonucleoprotein A1 is identified as a potential biomarker for colorectal cancer based on differential proteomics technology.
Ma YL; Peng JY; Zhang P; Huang L; Liu WJ; Shen TY; Chen HQ; Zhou YK; Zhang M; Chu ZX; Qin HL
J Proteome Res; 2009 Oct; 8(10):4525-35. PubMed ID: 19715280
[TBL] [Abstract][Full Text] [Related]
2. Proteomics identification of desmin as a potential oncofetal diagnostic and prognostic biomarker in colorectal cancer.
Ma Y; Peng J; Liu W; Zhang P; Huang L; Gao B; Shen T; Zhou Y; Chen H; Chu Z; Zhang M; Qin H
Mol Cell Proteomics; 2009 Aug; 8(8):1878-90. PubMed ID: 19460759
[TBL] [Abstract][Full Text] [Related]
3. Heterogeneous nuclear ribonucleoprotein K (hnRNP K) is a tissue biomarker for detection of early hepatocellular carcinoma in patients with cirrhosis.
Guo Y; Zhao J; Bi J; Wu Q; Wang X; Lai Q
J Hematol Oncol; 2012 Jul; 5():37. PubMed ID: 22760167
[TBL] [Abstract][Full Text] [Related]
4. Up-regulation of hnRNP A1, Ezrin, tubulin β-2C and Annexin A1 in sentinel lymph nodes of colorectal cancer.
He ZY; Wen H; Shi CB; Wang J
World J Gastroenterol; 2010 Oct; 16(37):4670-6. PubMed ID: 20872967
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of HnRNP A1 promotes tumor invasion through regulating CD44v6 and indicates poor prognosis for hepatocellular carcinoma.
Zhou ZJ; Dai Z; Zhou SL; Fu XT; Zhao YM; Shi YH; Zhou J; Fan J
Int J Cancer; 2013 Mar; 132(5):1080-9. PubMed ID: 22821376
[TBL] [Abstract][Full Text] [Related]
6. microRNA-26a and -584 inhibit the colorectal cancer progression through inhibition of the binding of hnRNP A1-CDK6 mRNA.
Konishi H; Fujiya M; Ueno N; Moriichi K; Sasajima J; Ikuta K; Tanabe H; Tanaka H; Kohgo Y
Biochem Biophys Res Commun; 2015 Nov; 467(4):847-52. PubMed ID: 26494299
[TBL] [Abstract][Full Text] [Related]
7. Identification of HnRNP M as a novel biomarker for colorectal carcinoma by quantitative proteomics.
Chen S; Zhang J; Duan L; Zhang Y; Li C; Liu D; Ouyang C; Lu F; Liu X
Am J Physiol Gastrointest Liver Physiol; 2014 Mar; 306(5):G394-403. PubMed ID: 24381081
[TBL] [Abstract][Full Text] [Related]
8. Aptamer BC15 against heterogeneous nuclear ribonucleoprotein A1 has potential value in diagnosis and therapy of hepatocarcinoma.
Li S; Wang W; Ding H; Xu H; Zhao Q; Li J; Li H; Xia W; Su X; Chen Y; Fang T; Shao N; Zhang H
Nucleic Acid Ther; 2012 Dec; 22(6):391-8. PubMed ID: 23062008
[TBL] [Abstract][Full Text] [Related]
9. HnRNP K and PDI marked response to chemotherapy to human colorectal cancer cells.
Zhang P; Huang L; Ma YL; Peng JY; Shen TY; Chen HQ; Zhou YK; Zhang M; Chu ZX; Qin HL
Electrophoresis; 2010 May; 31(10):1731-8. PubMed ID: 20408130
[TBL] [Abstract][Full Text] [Related]
10. Identification of prohibitin as a potential biomarker for colorectal carcinoma based on proteomics technology.
Chen D; Chen F; Lu X; Yang X; Xu Z; Pan J; Huang Y; Lin H; Chi P
Int J Oncol; 2010 Aug; 37(2):355-65. PubMed ID: 20596663
[TBL] [Abstract][Full Text] [Related]
11. A rat-to-human search for proteomic alterations reveals transgelin as a biomarker relevant to colorectal carcinogenesis and liver metastasis.
Peng J; Zhang Q; Ma Y; Wang Y; Huang L; Zhang P; Chen J; Qin H
Electrophoresis; 2009 Sep; 30(17):2976-2987. PubMed ID: 19711377
[TBL] [Abstract][Full Text] [Related]
12. Proteomic profiling of proteins associated with lymph node metastasis in colorectal cancer.
Ma Y; Zhao M; Zhong J; Shi L; Luo Q; Liu J; Wang J; Yuan X; Huang C
J Cell Biochem; 2010 Aug; 110(6):1512-9. PubMed ID: 20524204
[TBL] [Abstract][Full Text] [Related]
13. Identification of differentially-expressed proteins between early submucosal non-invasive and invasive colorectal cancer using 2D-DIGE and mass spectrometry.
Zhang J; Song MQ; Zhu JS; Zhou Z; Xu ZP; Chen WX; Chen NW
Int J Immunopathol Pharmacol; 2011; 24(4):849-59. PubMed ID: 22230392
[TBL] [Abstract][Full Text] [Related]
14. Identification of HSP27 as a potential tumor marker for colorectal cancer by the two-dimensional polyacrylamide gel electrophoresis.
Liu W; Ma Y; Huang L; Peng J; Zhang P; Zhang H; Chen J; Qin H
Mol Biol Rep; 2010 Oct; 37(7):3207-16. PubMed ID: 19842058
[TBL] [Abstract][Full Text] [Related]
15. Up-regulation of hnRNP A1 gene in sporadic human colorectal cancers.
Ushigome M; Ubagai T; Fukuda H; Tsuchiya N; Sugimura T; Takatsuka J; Nakagama H
Int J Oncol; 2005 Mar; 26(3):635-40. PubMed ID: 15703818
[TBL] [Abstract][Full Text] [Related]
16. Heterogeneous nuclear ribonucleoprotein A2/B1 in association with hTERT is a potential biomarker for hepatocellular carcinoma.
Mizuno H; Honda M; Shirasaki T; Yamashita T; Yamashita T; Mizukoshi E; Kaneko S
Liver Int; 2012 Aug; 32(7):1146-55. PubMed ID: 22372738
[TBL] [Abstract][Full Text] [Related]
17. microRNA-18a induces apoptosis in colon cancer cells via the autophagolysosomal degradation of oncogenic heterogeneous nuclear ribonucleoprotein A1.
Fujiya M; Konishi H; Mohamed Kamel MK; Ueno N; Inaba Y; Moriichi K; Tanabe H; Ikuta K; Ohtake T; Kohgo Y
Oncogene; 2014 Oct; 33(40):4847-56. PubMed ID: 24166503
[TBL] [Abstract][Full Text] [Related]
18. Identification of apoptosis-associated proteins in a human Burkitt lymphoma cell line. Cleavage of heterogeneous nuclear ribonucleoprotein A1 by caspase 3.
Brockstedt E; Rickers A; Kostka S; Laubersheimer A; Dörken B; Wittmann-Liebold B; Bommert K; Otto A
J Biol Chem; 1998 Oct; 273(43):28057-64. PubMed ID: 9774422
[TBL] [Abstract][Full Text] [Related]
19. Stroma derived COL6A3 is a potential prognosis marker of colorectal carcinoma revealed by quantitative proteomics.
Qiao J; Fang CY; Chen SX; Wang XQ; Cui SJ; Liu XH; Jiang YH; Wang J; Zhang Y; Yang PY; Liu F
Oncotarget; 2015 Oct; 6(30):29929-46. PubMed ID: 26338966
[TBL] [Abstract][Full Text] [Related]
20. Identification of serum biomarkers for colorectal cancer metastasis using a differential secretome approach.
Xue H; Lü B; Zhang J; Wu M; Huang Q; Wu Q; Sheng H; Wu D; Hu J; Lai M
J Proteome Res; 2010 Jan; 9(1):545-55. PubMed ID: 19924834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
